Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Integra Lifesciences Holdings (IART) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Integra Lifesciences Holdings (IART) over the last 17 years, with Q3 2025 value amounting to $364.1 million.

  • Integra Lifesciences Holdings' Total Current Liabilities fell 6010.64% to $364.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $364.1 million, marking a year-over-year decrease of 6010.64%. This contributed to the annual value of $922.1 million for FY2024, which is 20038.63% up from last year.
  • According to the latest figures from Q3 2025, Integra Lifesciences Holdings' Total Current Liabilities is $364.1 million, which was down 6010.64% from $929.8 million recorded in Q2 2025.
  • Integra Lifesciences Holdings' Total Current Liabilities' 5-year high stood at $929.8 million during Q2 2025, with a 5-year trough of $282.3 million in Q1 2023.
  • Moreover, its 5-year median value for Total Current Liabilities was $332.9 million (2021), whereas its average is $454.8 million.
  • Data for Integra Lifesciences Holdings' Total Current Liabilities shows a peak YoY increase of 20372.69% (in 2025) and a maximum YoY decrease of 6010.64% (in 2025) over the last 5 years.
  • Integra Lifesciences Holdings' Total Current Liabilities (Quarter) stood at $340.0 million in 2021, then fell by 5.62% to $320.9 million in 2022, then dropped by 4.34% to $307.0 million in 2023, then surged by 200.39% to $922.1 million in 2024, then crashed by 60.52% to $364.1 million in 2025.
  • Its Total Current Liabilities stands at $364.1 million for Q3 2025, versus $929.8 million for Q2 2025 and $918.5 million for Q1 2025.